THE EFFECT OF REDUCED-DOSE ORAL GLUCOCORTICOIDS DURING INDUCTION OF REMISSION INDUCTION IN SEVERE ANCA-ASSOCIATED VASCULITIS

被引:0
|
作者
Walsh, Michael [1 ]
Merkel, Peter [2 ]
Jayne, David [3 ]
机构
[1] McMaster Univ, St Josephs Healthcare, Hamilton, ON, Canada
[2] Univ Penn, Philadelphia, PA 19104 USA
[3] Univ Cambridge, Addenbrookes Hosp, Cambridge, England
基金
美国国家卫生研究院; 英国医学研究理事会; 芬兰科学院; 加拿大健康研究院;
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
361
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Proteinuria and hematuria after remission induction are associated with outcome in ANCA-associated vasculitis
    Benichou, Nicolas
    Charles, Pierre
    Terrier, Benjamin
    Jones, Rachel B.
    Hiemstra, Thomas
    Mouthon, Luc
    Bajema, Ingeborg
    Berden, Annelies
    Thervet, Eric
    Guillevin, Loic
    Jayne, David
    Karras, Alexandre
    KIDNEY INTERNATIONAL, 2023, 103 (06) : 1144 - 1155
  • [22] Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis
    Walsh, Michael
    Merkel, Peter A.
    Peh, Chen-Au
    Szpirt, Wladimir M.
    Puechal, Xavier
    Fujimoto, Shouichi
    Hawley, Carmel M.
    Khalidi, Nader
    Flossmann, Oliver
    Wald, Ron
    Girard, Louis P.
    Levin, Adeera
    Gregorini, Gina
    Harper, Lorraine
    Clark, William F.
    Pagnoux, Christian
    Specks, Ulrich
    Smyth, Lucy
    Tesar, Vladimir
    Ito-Ihara, Toshiko
    de Zoysa, Janak Rashme
    Szczeklik, Wojciech
    Flores-Suarez, Luis Felipe
    Carette, Simon
    Guillevin, Loic
    Pusey, Charles D.
    Casian, Alina L.
    Brezina, Biljana
    Mazzetti, Andrea
    McAlear, Carol A.
    Broadhurst, Elizabeth
    Reidlinger, Donna
    Mehta, Samir
    Ives, Natalie
    Jayne, David R. W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (07): : 622 - 631
  • [23] Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis
    Sexton, Donal J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (22): : 2168 - 2168
  • [24] B cell-driven reduced-dose rituximab as induction therapy for 2 patients with ANCA-associated renal vasculitis: A case series
    Wang, Qinglian
    Wang, Simeng
    Liu, Xiang
    Cheng, Fajuan
    Xu, Ying
    CLINICAL NEPHROLOGY, 2025, 103 (02) : 140 - 147
  • [25] Pulse vs daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: a randomized controlled trial
    Harper, Lorraine
    De Groot, Kirsten
    Jayne, David
    Flores Suarez, Luis Felipe
    Gregorini, Gina
    Gross, Wolfgang
    Luqmani, Rashid
    Pusey, Charles
    Rasmussen, Niels
    Sinico, Renato
    Tesar, Vladimir
    Vanhille, Philippe
    Westman, Kerstin
    Savage, Caroline
    APMIS, 2009, 117 : 77 - 77
  • [26] Safety Of Remission Induction With Rituximab Versus Cyclosphosphamide In Patients 65 and Older With Severe ANCA-Associated Vasculitis
    Miloslavsky, Eli
    Specks, Ulrich
    Merkel, Peter A.
    Seo, Philip
    Spiera, Robert F.
    Langford, Carol A.
    Hoffman, Gary S.
    Kallenberg, Cees G. M.
    St Clair, E. William
    Tchao, Nadia
    Ding, Linna
    Ikle, David
    Jepson, Brett
    Brunetta, Paul
    Stone, John H.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S313 - S313
  • [27] Safety of remission induction with rituximab versus cyclophosphamide in patients 65 and older with severe ANCA-associated vasculitis
    Miloslavsky, E.
    Specks, U.
    Merkel, P.
    Seo, P.
    Spiera, R.
    Langford, C.
    Hoffman, G.
    Kallenberg, C.
    St Clair, W.
    Tchao, N.
    Ding, L.
    Ikle, D.
    Jepson, B.
    Brunetta, P.
    Stone, J.
    PRESSE MEDICALE, 2013, 42 (04): : 779 - 780
  • [28] Induction Regimens for ANCA-Associated Vasculitis REPLY
    Specks, Ulrich
    Ikle, David
    Stone, John H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (19): : 1865 - 1866
  • [29] Comment on: Induction treatment of ANCA-associated vasculitis with a single dose of rituximab
    Moog, Philipp
    Schulze-Koops, Hendrik
    Thuermel, Klaus
    RHEUMATOLOGY, 2015, 54 (02) : 372 - 373
  • [30] Low-dose rituximab as induction therapy for ANCA-associated vasculitis
    Yukiko Takakuwa
    Hironari Hanaoka
    Tomofumi Kiyokawa
    Harunobu Iida
    Hisae Fujimoto
    Yoshioki Yamasaki
    Hidehiro Yamada
    Kimito Kawahata
    Clinical Rheumatology, 2019, 38 : 1217 - 1223